Michael E. Cloesmeijer
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.
Journal: European journal of drug metabolism and pharmacokinetics
Published: January 16, 2024
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 15, 2023
ChatGPT in pharmacometrics? Potential opportunities and limitations.
Journal: British journal of clinical pharmacology
Published: April 24, 2023
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.
Journal: BMJ open
Published: February 16, 2022
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 20, 2021
Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics.
Journal: British journal of clinical pharmacology
Published: November 13, 2019
Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis.
Journal: British journal of clinical pharmacology
Published: September 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026